Sleep Medicine News

CHARLOTTE, N.C. – Results from the Wake Up America poll showed that practitioners do not often ask patients about insomnia, and patients may be hesitant to discuss it, Andrew Krystal, MD, MS, said at the SLEEP meeting.

Jazz Pharmaceuticals announced it has entered into a licensing agreement with Sumitomo Pharma Co. to develop and commercialize an oral treatment for narcolepsy, idiopathic hypersomnia and other sleep disorders.

CHARLOTTE, N.C. — Cognitive behavioral therapy for insomnia is a “feasible and acceptable” treatment for people regularly using cannabis to help with sleep, J. Todd Arnedt, PhD, said at the SLEEP 2022 meeting.

CHARLOTTE, N.C. – The side effect profile of lower-sodium oxybate was similar to that seen in previous sodium oxybate trials when being used to treat idiopathic hypersomnia, Richard K. Bogan, MD, FCCP, FAASM, said at SLEEP 2022.

CHARLOTTE, N.C. — The use of morning light treatment in patients with fibromyalgia helped stabilize their sleep and led to improvements in pain and physical function, Helen J. Burgess, PhD, said at the SLEEP 2022 meeting.

CHARLOTTE, N.C. – A study showed a stronger association between atrial fibrillation and hypoxemia measures vs. the apnea hypopnea index, which is commonly used in sleep studies, Catherine Heinzinger, DO, said at the SLEEP 2022 meeting.

CHARLOTTE, N.C. – Researchers found that sleep variability, depression and age significantly predicted cognitive impairment at 10 years, according to a study presented here at SLEEP 2022.

CHARLOTTE, N.C. — More than 50% of patients who came to an academic health care center with cardiac or neurological conditions also were found to have sleep apnea or other sleep disturbances, according to a study presented at SLEEP 2022.

CHARLOTTE, N.C. — A history of COVID-19 nearly doubled the odds of having very short sleep, according to results from a large U.S. study presented at SLEEP 2022.

CHARLOTTE, N.C. — Pupillary light reflex testing may hold potential in detecting a hyperarousal subtype of patients with insomnia, William Vaughn McCall, MD, said at the SLEEP 2022 meeting.